Study of evaluation for efficacy and safety of SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics

Study of evaluation for efficacy and safety of SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics - SMART(Symbicort Maintenance and Reliever Therapy) in poorly controlled asthmatics

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010825

Enrollment

Registered

2013-05-29

Start date

2013-05-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

SMART(Symbicort Maintenance and Reliever Therapy)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: poorly controlled asthmatics (ACT score<=24)

Exclusion criteria

Exclusion criteria: contraindications of Symbicort current smoker Infections within 2 weeks Systemic steroid administration within 2 weeks Pregnant patients

Design outcomes

Primary

Measure	Time frame
ACT score	—

Countries

Japan

Contacts

Public ContactKazuhisa Asai

Graduate school of medicine, Osaka City University Department of Respiratory medicine

kokyuki@med.osaka-cu.ac.jp06-6645-3916

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026